J.W. Cole Advisors’s Zimmer Biomet ZBH Stock Holding History

J.W. Cole Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	2,900 +21	+0.7%	+$1.84K	﹤0.01%	1378
2026 Q1	$260K	Sell	2,879 -852	-23%	-$78.2K	0.01%	668
2025 Q4	$324K	Sell	3,731 -582	-13%	-$55.2K	0.01%	1071
2025 Q3	$425K	Buy	4,313 +407	+10%	+$40.3K	0.01%	1063
2025 Q2	$356K	Buy	3,906 +481	+14%	+$46.5K	0.01%	1056
2025 Q1	$388K	Buy	+3,425	New	+$366K	0.01%	853
2020 Q4	–	Sell	-1,530	Closed	-$202K	–	893
2020 Q3	$202K	Buy	+1,530	New	+$200K	0.02%	675

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

J.W. Cole Advisors's ZBH Position: Q2 2026 in Review

J.W. Cole Advisors increased its Zimmer Biomet (ZBH) stake by 0.73% in Q2 2026, buying an estimated $1.84K and bringing the position to 2,900 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

J.W. Cole Advisors first reported a position in ZBH in Q3 2020 and has held it in 7 quarters since. The position peaked at $425K in Q3 2025. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

J.W. Cole Advisors held 2,900 shares of Zimmer Biomet worth $250K as of Q2 2026.
J.W. Cole Advisors bought 21 Zimmer Biomet shares in Q2 2026, an estimated $1.84K.
Zimmer Biomet made up ﹤0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1378 holding.
J.W. Cole Advisors first reported a position in Zimmer Biomet in Q3 2020 and has held it in 7 quarters since.
J.W. Cole Advisors's Zimmer Biomet position peaked at $425K in Q3 2025.
150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.